FG
LUNG icon

Formula Growth’s Pulmonx LUNG Stock Holding History

Formula Growth’s Portfolio LUNG Stock Details LUNG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-20,034
Closed -$334K – 138
2022
Q3 		$334K Sell
20,034
-34,917
-64% -$643K 0.1% 120
2022
Q2 		$809K Hold
54,951
– – 0.22% 108
2022
Q1 		$1.36M Sell
54,951
-3,723
-6% -$96.2K 0.26% 102
2021
Q4 		$1.88M Sell
58,674
-1,326
-2% -$48.4K 0.33% 90
2021
Q3 		$2.16M Buy
+60,000
New +$2.36M 0.31% 94

Other funds holding LUNG

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
KXA
KPCB XIII Associates Menlo Park, California $186M AUM 11.23% 1-Year Est. Return

Formula Growth's LUNG Position: Q4 2022 in Review

Formula Growth sold out of Pulmonx (LUNG) in Q4 2022, closing a stake of 20,034 shares — an estimated $334K sold.

Formula Growth first reported a position in LUNG in Q3 2021 and held it in 5 quarters. The position peaked at $2.16M in Q3 2021. 116 funds tracked by Wall St. Rank hold LUNG as of Q4 2022.

  • Formula Growth reported no remaining Pulmonx position as of Q4 2022 after selling out during the quarter.
  • Formula Growth sold 20,034 Pulmonx shares in Q4 2022, an estimated $334K.
  • Formula Growth first reported a position in Pulmonx in Q3 2021 and held it in 5 quarters.
  • Formula Growth's Pulmonx position peaked at $2.16M in Q3 2021.
  • 116 funds tracked by Wall St. Rank held Pulmonx as of Q4 2022.

Based on Formula Growth's 13F filing for Q4 2022, filed 13 Feb 2023.